Related references
Note: Only part of the references are listed.Dopa-decarboxylase gene polymorphisms affect the motor response to L-dopa in Parkinson's disease
David Devos et al.
PARKINSONISM & RELATED DISORDERS (2014)
Methylphenidate A Treatment for Parkinson's Disease?
David Devos et al.
CNS DRUGS (2013)
The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism
Stephan Klebe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial (vol 11, pg 589, 2012)
C. Moreau et al.
LANCET NEUROLOGY (2012)
Freezer or non-freezer: Clinical assessment of freezing of gait
Anke H. Snijders et al.
PARKINSONISM & RELATED DISORDERS (2012)
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial
Caroline Moreau et al.
LANCET NEUROLOGY (2012)
The COMT Val158Met Polymorphism Affects the Response to Entacapone in Parkinson's Disease: A Randomized Crossover Clinical Trial
Jean-Christophe Corvol et al.
ANNALS OF NEUROLOGY (2011)
Procedure-Type Risk Categories for Pediatric and Congenital Cardiac Catheterization
Lisa Bergersen et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
Freezing of gait: moving forward on a mysterious clinical phenomenon
John G. Nutt et al.
LANCET NEUROLOGY (2011)
Catechol-O-methyltransferase Val158Met and Cognitive Function in Parkinson's Disease
Jeroen Hoogland et al.
MOVEMENT DISORDERS (2010)
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
K. Ray Chaudhuri et al.
LANCET NEUROLOGY (2009)
Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation
Michael J. Frank et al.
NATURE NEUROSCIENCE (2009)
Variation in dopamine genes influences responsivity of the human reward system
Jean-Claude Dreher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity
E. E. Forbes et al.
MOLECULAR PSYCHIATRY (2009)
Pharmacokinetics and pharmacodynamics of levodopa
John G. Nutt
MOVEMENT DISORDERS (2008)
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications
Monika Bialecka et al.
PHARMACOGENETICS AND GENOMICS (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample
C Guindalini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
The variable number of tandem repeats element in DATI regulates in vitro dopamine transporter density -: art. no. 55
SH VanNess et al.
BMC GENETICS (2005)
Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men
P Costa-Mallen et al.
NEUROSCIENCE LETTERS (2005)
Calculating total electrical energy delivered by deep brain stimulation systems
AM Koss et al.
ANNALS OF NEUROLOGY (2005)
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic -: Pharmacodynarnic pattern in patients with Parkinson's disease
M Contin et al.
MOVEMENT DISORDERS (2005)
Dopamine transporter gene polymorphism, SPECT imaging, and levodopa response in patients with Parkinson disease
M Contin et al.
CLINICAL NEUROPHARMACOLOGY (2004)
Presynaptic mechanisms of motor fluctuations in Parkinson's disease:: a probabilistic model
R de la Fuente-Fernández et al.
BRAIN (2004)
The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease
M Bialecka et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease
P Krack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism
GR Uhl
MOVEMENT DISORDERS (2003)
Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease
M Watanabe et al.
NEUROPSYCHOBIOLOGY (2003)
Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals
DV Zaykin et al.
HUMAN HEREDITY (2002)
Genotypes of catechol-O-methyltransferase and response to levodopa treatment in patients with Parkinson's disease
MS Lee et al.
NEUROSCIENCE LETTERS (2001)
Share Paper
